• Novo Nordisk EPS for the quarter ending March 31, 2026 was $1.71, a 85.56% increase year-over-year.
• Novo Nordisk 2025 annual EPS was $3.49, a 6.28% increase from 2024.
• Novo Nordisk 2024 annual EPS was $3.28, a 21.34% increase from 2023.
• Novo Nordisk 2023 annual EPS was $2.7, a 56.3% increase from 2022.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.